Sorteer per
Medicine and Dentistry
(3 Iodobenzyl)guanidine
19%
Adolescence
22%
Adverse Event
6%
Body Mass Index
13%
Bone Density
10%
Cancer in Young Adults
20%
Cancer Therapy
10%
Chemotherapy
9%
Childhood Cancer
100%
Cohort Analysis
8%
Craniopharyngioma
20%
Diagnosis
8%
Differentiated Thyroid Cancer
48%
Disease
7%
Endocrine Disease
19%
Endocrinology
9%
Fertility Preservation
15%
Ganglioglioma
8%
Ganglioneuroblastoma
25%
Growth Hormone
7%
Growth Hormone Deficiency
8%
Health Outcomes
11%
Hypothalamus Disease
7%
Hypothyroidism
13%
Intracranial Tumor
17%
Iodine 131
22%
Late Effect
27%
Malignant Neoplasm
23%
Metabolic Syndrome
8%
Multiple Endocrine Neoplasia
8%
Multiple Endocrine Neoplasia Type 2b
7%
Neck
8%
Neoplasm
22%
Pediatrics
34%
Potassium Iodide
6%
Prevalence
24%
Primary Ovarian Insufficiency
7%
Quality of Life
14%
Radiation Therapy
13%
Radiation Therapy
7%
Radioactive Iodine
9%
Recurrent Disease
10%
Systematic Review
18%
Thyroid Cancer
15%
Thyroid Disease
16%
Thyroid Function
8%
Thyroid Gland
19%
Thyroid Medullary Carcinoma
6%
Thyrotropin
9%
Thyroxine
11%
Keyphrases
123I-MIBG
8%
131I-metaiodobenzylguanidine
13%
131I-MIBG
7%
Adult Cancer
14%
Body Mass Index
7%
Cancer Guidelines
14%
Chemotherapy
8%
Childhood Cancer
34%
Childhood Cancer Survivor Study
7%
Childhood Cancer Survivors
33%
Childhood-onset
7%
Congenital Hypothyroidism
7%
Consensus Statement
9%
CORDIS
7%
Craniopharyngioma
17%
Differentiated Thyroid Cancer
16%
Differentiated Thyroid Carcinoma
24%
Dutch
20%
Endocrine Disorders
14%
Endocrinology
9%
European Society
7%
Fertility Preservation
12%
Growth Hormone Treatment
6%
Hypothalamic Obesity
11%
Hypothalamic-pituitary Axis
15%
Hypothyroidism
8%
International Consensus
12%
Late Effects
19%
Long-term Survivors
10%
Measuring Quality
7%
Multiple Endocrine Neoplasia Type 2 (MEN2)
9%
Neuroblastoma
23%
Pituitary Dysfunction
9%
Potassium Iodide
6%
Prevalence Risk
6%
Project Research
9%
Quality of Life
7%
Quality of Survival
12%
Radiotherapy
12%
Research Funding
7%
Risk Factors
16%
Strategic Research
7%
Survivors
36%
Thyroid Cancer
10%
Thyroid Dysfunction
14%
Thyroid Function
8%
Thyroid Gland
13%
Thyroid Hormones
7%
Thyroxine
8%
Working Diagnosis
10%
